Biotricity (OTCMKTS:BTCY) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Biotricity (OTCMKTS:BTCY) issued its quarterly earnings results on Wednesday. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06, Zacks reports.

Biotricity Stock Up 10.0 %

BTCY stock opened at $0.66 on Thursday. The company’s 50-day moving average price is $0.36 and its two-hundred day moving average price is $0.36. Biotricity has a 12 month low of $0.19 and a 12 month high of $1.67. The firm has a market cap of $16.21 million, a P/E ratio of -0.39 and a beta of 1.18.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.